These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19764836)

  • 1. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans.
    Clausen TS; Kaastrup P; Stallknecht B
    Diabetes Technol Ther; 2009 Sep; 11(9):575-80. PubMed ID: 19764836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of steel and teflon infusion catheters on subcutaneous adipose tissue blood flow and infusion counter pressure in humans.
    Højbjerre L; Skov-Jensen C; Kaastrup P; Pedersen PE; Stallknecht B
    Diabetes Technol Ther; 2009 May; 11(5):301-6. PubMed ID: 19425878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: an exploratory study.
    Naik S; Kerr D; Begley J; Morton J
    Diabetes Technol Ther; 2012 Nov; 14(11):1018-22. PubMed ID: 23101952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects.
    Mudaliar SR; Lindberg FA; Joyce M; Beerdsen P; Strange P; Lin A; Henry RR
    Diabetes Care; 1999 Sep; 22(9):1501-6. PubMed ID: 10480516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine.
    Hauzenberger JR; Hipszer BR; Loeum C; McCue PA; DeStefano M; Torjman MC; Kaner MT; Dinesen AR; Chervoneva I; Pieber TR; Joseph JI
    Diabetes Technol Ther; 2017 Nov; 19(11):641-650. PubMed ID: 28981324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dynamics of the microcirculation in the subcutaneous adipose tissue is impaired in the postprandial state in type 2 diabetes.
    Tobin L; Simonsen L; Bülow J
    Clin Physiol Funct Imaging; 2011 Nov; 31(6):458-63. PubMed ID: 21981457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart.
    Ihlo CA; Lauritzen T; Sturis J; Skyggebjerg O; Christiansen JS; Laursen T
    Diabet Med; 2011 Feb; 28(2):230-6. PubMed ID: 21219436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
    Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
    Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to increase postprandial blood flow in subcutaneous adipose tissue is associated with tissue resistance to adrenergic stimulation.
    Ardilouze JL; Sotorník R; Dennis LA; Fielding BA; Frayn KN; Karpe F
    Diabetes Metab; 2012 Feb; 38(1):27-33. PubMed ID: 21865069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blunted effect of glucose-dependent insulinotropic polypeptide in subcutaneous abdominal adipose tissue in obese subjects is partly reversed by weight loss.
    Asmar M; Arngrim N; Simonsen L; Asmar A; Nordby P; Holst JJ; Bülow J
    Nutr Diabetes; 2016 May; 6(5):e208. PubMed ID: 27136446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of insulin aspart, a rapid-acting analog of human insulin, in healthy Japanese volunteers.
    Kaku K; Matsuda M; Urae A; Irie S
    Diabetes Res Clin Pract; 2000 Aug; 49(2-3):119-26. PubMed ID: 10963823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
    Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
    J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of infusion rate and indwelling time on tissue resistance pressure in small-volume subcutaneous infusion like in continuous subcutaneous insulin infusion.
    Patte C; Pleus S; Wiegel C; Schiltges G; Jendrike N; Haug C; Freckmann G
    Diabetes Technol Ther; 2013 Apr; 15(4):289-94. PubMed ID: 23427865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming.
    Cengiz E; Weinzimer SA; Sherr JL; Tichy EM; Carria L; Cappiello D; Steffen A; Tamborlane WV
    Diabetes Technol Ther; 2014 Jan; 16(1):20-5. PubMed ID: 24367934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin glulisine has a faster onset of action compared with insulin aspart in healthy volunteers.
    Arnolds S; Rave K; Hövelmann U; Fischer A; Sert-Langeron C; Heise T
    Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):662-4. PubMed ID: 20429049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers.
    von Mach MA; Brinkmann C; Hansen T; Weilemann LS; Beyer J
    Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):416-9. PubMed ID: 12518253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-action profile and patient assessment of inhaled insulin via the Exubera device in comparison with subcutaneously injected insulin aspart via the FlexPen device.
    Forst T; Hohberg C; Schöndorf T; Borchert M; Forst S; Roth W; Dehos B; Pfützner A
    Diabetes Technol Ther; 2009 Feb; 11(2):87-92. PubMed ID: 19848574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent delay of the hypoglycemic effect of short-acting insulin analogs in obese subjects with type 2 diabetes: a pharmacokinetic and pharmacodynamic study.
    Gagnon-Auger M; du Souich P; Baillargeon JP; Martin E; Brassard P; Ménard J; Ardilouze JL
    Diabetes Care; 2010 Dec; 33(12):2502-7. PubMed ID: 20841613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin Bolus Administration in Insulin Pump Therapy: Effect of Bolus Delivery Speed on Insulin Absorption from Subcutaneous Tissue.
    Regittnig W; Urschitz M; Lehki B; Wolf M; Kojzar H; Mader JK; Ellmerer M; Pieber TR
    Diabetes Technol Ther; 2019 Jan; 21(1):44-50. PubMed ID: 30620643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.